Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

IMARC Group's report titled “Oxygenators Market Report by Type (Membrane Oxygenator, Bubble Oxygenator), Age Group (Neonates, Pediatric, Adults), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary, Resuscitation (ECPR)), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the global oxygenators market share. The global market size reached US$ 258.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 411.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/oxygenators-market/requestsample

Factors Affecting the Growth of the Oxygenators Industry:

  • Technological Advancements in Oxygenators:

Manufacturers are focusing on developing more efficient, compact, and user-friendly oxygenators that offer improved gas exchange capabilities, reduced priming volumes, and enhanced patient safety. This consists of innovations like miniaturized oxygenators for pediatric and neonatal patients, integrated heat exchangers for temperature control, and oxygenators equipped with advanced coating technologies to prevent blood clotting and reduce inflammation. These advancements not only improve the clinical outcomes for patients requiring extracorporeal membrane oxygenation (ECMO) therapy but also contribute to the operational efficiency within healthcare settings.

  • Growing Surgical Procedures Requiring Cardiopulmonary Support:

The increasing number of surgical procedures that necessitate cardiopulmonary bypass (CPB) support is catalyzing the demand for oxygenators. Cardiac surgeries, including coronary artery bypass grafting (CABG), heart valve repair or replacement, and congenital heart defect corrections, require the use of CPB machines and oxygenators to maintain blood oxygenation and circulation during the operation. The rise in cardiovascular diseases, driven by lifestyle factors, aging populations, and improved diagnostic capabilities, is resulting in an uptick in these surgeries, which is driving the need for reliable and efficient oxygenation systems. This factor ensures a steady demand for advanced oxygenators capable of supporting the physiological needs of patients during complex surgical interventions.

  • Emphasis on Minimally Invasive (MI) Procedures:

The growing shift towards minimally invasive surgeries (MIS) across various medical specialties is positively influencing the market. MIS techniques are preferred for their benefits, such as reduced hospital stays, lower infection rates, and quicker recovery times compared to traditional open surgeries. This shift is leading to the development of compact and more efficient oxygenators that are compatible with the requirements of MIS. These procedures often require sophisticated equipment that can provide the necessary support without the invasiveness of traditional methods. This not only highlights the technological advancements in medical procedures but also the adaptability of oxygenators to meet evolving surgical needs.

Leading Companies Operating in the Global Oxygenators Industry:

  • Braile Biomédica
  • Chalice Medical Ltd
  • Eurosets S.r.l.
  • Getinge AB
  • Livanova Plc
  • Medtronic plc
  • MicroPort
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Terumo Medical Corporation (Terumo Corporation)
  • Xenios AG (Fresenius Medical Care AG & Co. KGaA)

Oxygenators Market Report Segmentation:

By Type:

  • Membrane Oxygenator
  • Bubble Oxygenator

Membrane oxygenator exhibits a clear dominance in the market due to its efficiency in gas exchange and lower risk of blood damage compared to other types.

By Age Group:

  • Neonates
  • Pediatric
  • Adults

Based on the age group, the market has been segregated into neonates, pediatric, and adults.

By Application:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary
  • Resuscitation (ECPR)

Respiratory holds the biggest market attributed to the high prevalence of respiratory diseases and conditions requiring oxygenation support.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America dominates the market owing to the existence of advanced healthcare infrastructure and the presence of key oxygenator manufacturers.

Global Oxygenators Market Trends:

The advent of smart oxygenators equipped with sensors and internet of things (IoT) capabilities, enabling real-time monitoring of oxygenation levels, blood flow, and other critical parameters, is offering a favorable market outlook. This technological integration facilitates enhanced patient monitoring, allowing healthcare professionals to make more informed decisions and adjustments in real time, thereby improving patient outcomes.

Additionally, the increasing focus on personalized medicine is leading to the development of oxygenators that can be tailored to individual patient needs, taking into account factors like age, size, and specific health conditions. This customization is particularly relevant in pediatric and neonatal care, where the precise delivery of oxygenation support is critical.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163